Galecto Inc
NASDAQ:GLTO
Galecto Inc
Other Equity
Galecto Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Other Equity
$379.7k
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Other Equity
kr22.7m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Other Equity
-€246m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Other Equity
-kr25.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
Bioporto A/S
CSE:BIOPOR
|
Other Equity
kr80k
|
CAGR 3-Years
-55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Galecto Inc's Other Equity?
Other Equity
379.7k
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Other Equity amounts to 379.7k USD.
What is Galecto Inc's Other Equity growth rate?
Other Equity CAGR 3Y
-18%
The average annual Other Equity growth rates for Galecto Inc have been -18% over the past three years .